This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $500 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

Ivelin Georgiev, PhD
Associate Professor of Pathology, Microbiology and Immunology at Vanderbilt University Medical Center


Dr. Georgiev received his Ph.D. in Computer Science from Duke University, after which he served as a staff scientist and co-head of the Structural Bioinformatics Core Section at the Vaccine Research Center, NIH. Dr. Georgiev is currently an Associate Professor in the Departments of Pathology, Microbiology, and Immunology and of Computer Science at Vanderbilt. Since 2020, he has served as the Director of Graduate Studies for the Vanderbilt Program in Chemical and Physical Biology. Dr. Georgiev is the founding Director of the Vanderbilt Program in Computational Microbiology and Immunology, a program focused on supporting research, educational, and strategic efforts that aim to employ the power of computation toward the development and application of innovative approaches for treatment and prevention of disease and for enhancement of human health. Dr. Georgiev’s research is focused on the development and application of technologies related to problems in the fields of immunology and virology, with a special emphasis on structure-based vaccine design and antibody discovery and optimization.

Agenda Sessions

  • Linking B Cell Receptor to Antigen Specificity through Sequencing and Ligand Blocking